Search Results - "Cummings, Carrie"

Refine Results
  1. 1
  2. 2

    Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets by Morris, Valerie A., Cummings, Carrie L., Korb, Brendan, Boaglio, Sean, Oehler, Vivian G.

    Published in Molecular and cellular biology (01-02-2016)
    “…Acute myeloid leukemia (AML) is characterized by increased proliferation and blocked differentiation of hematopoietic progenitors mediated, in part, by altered…”
    Get full text
    Journal Article
  3. 3

    The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia by Oehler, Vivian G., Gooley, Ted, Snyder, David S., Johnston, Laura, Lin, Allen, Cummings, Carrie C., Chu, Su, Bhatia, Ravi, Forman, Stephen J., Negrin, Robert S., Appelbaum, Frederick R., Radich, Jerald P.

    Published in Blood (15-02-2007)
    “…The impact of imatinib mesylate (IM) treatment for chronic myeloid leukemia (CML) on subsequent allogeneic transplantation is uncertain. To better understand…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Discovery of U2AF1 neoantigens in myeloid neoplasms by Biernacki, Melinda Ann, Lok, Jessica, Black, Ralph Graeme, Foster, Kimberly A, Cummings, Carrie, Woodward, Kyle B, Monahan, Tim, Oehler, Vivian G, Stirewalt, Derek L, Wu, David, Rongvaux, Anthony, Deeg, Hans Joachim, Bleakley, Marie

    Published in Journal for immunotherapy of cancer (12-12-2023)
    “…BackgroundMyelodysplastic syndromes (MDS) arise from somatic mutations acquired in hematopoietic stem and progenitor cells, causing cytopenias and predisposing…”
    Get full text
    Journal Article
  6. 6

    Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation by Heller, Paula G., Glembotsky, Ana C., Gandhi, Manish J., Cummings, Carrie L., Pirola, Carlos J., Marta, Rosana F., Kornblihtt, Laura I., Drachman, Jonathan G., Molinas, Felisa C.

    Published in Blood (15-06-2005)
    “…Germ-line heterozygous mutations in the hematopoietic transcription factor AML1 (RUNX1) have been identified in patients with familial platelet disorder with…”
    Get full text
    Journal Article
  7. 7

    Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation by Gandhi, Manish J., Pendergrass, Thomas W., Cummings, Carrie C., Ihara, Kenji, Blau, C. Anthony, Drachman, Jonathan G.

    Published in Experimental hematology (01-10-2005)
    “…An 11-year-old girl, presenting with fatigue and bruising, was found to be profoundly pancytopenic. Bone marrow exam and clinical evaluation were consistent…”
    Get full text
    Journal Article
  8. 8

    FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10 by Gandhi, Manish J, Cummings, Carrie L, Drachman, Jonathan G

    Published in Human heredity (01-01-2003)
    “…The gene for a novel nonsyndromic autosomal dominant thrombocytopenia has been previously mapped to a region on human chromosome 10p11-12 (THC2, OMIM number…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Custom High Throughput Drug Sensitivity Assay Reveals Therapeutic Options for Chronic Myeloid Leukemia Patients Resistant to or Intolerant of Tyrosine Kinase Inhibitors by Oehler, Vivian G., Chien, Sylvia, Dai, Jin, Cummings, Carrie L., Annis, James, Martins, Timothy J, Becker, Pamela S.

    Published in Blood (23-11-2021)
    “…Introduction. Tyrosine kinase inhibitors (TKIs) have revolutionized chronic phase (CP) chronic myeloid leukemia (CML) care with many patients achieving major…”
    Get full text
    Journal Article
  11. 11

    Myeloid/Lymphoid Neoplasm with Eosinophilia and a Novel RUFY1-Pdgfrb Rearrangement by Williams Silva, Karly, Cummings, Carrie L., Rashid, Nahid, Sala-Torra, Olga, Chen, Xueyan, Liu, Yajuan J., Oehler, Vivian G.

    Published in Blood (23-11-2021)
    “…▪ Myeloid/lymphoid neoplasms associated with eosinophilia (MLN-Eo) and tyrosine kinase fusion genes include rearrangements of PDGFRB with over 30 different…”
    Get full text
    Journal Article
  12. 12

    A Shared SF3B1 Neoantigen Is Presented on Primary Malignant Cells and Induced Pluripotent Stem Cell-Derived Hematopoietic Lines by Biernacki, Melinda Ann, Foster, Kimberly A, Clough, Courtnee, Busch, Stephanie, Cummings, Carrie, Oehler, Vivian G., Stirewalt, Derek, Doulatov, Sergei, Bleakley, Marie

    Published in Blood (05-11-2020)
    “…Myeloid malignancies are susceptible to immunologic destruction but antigen-specific T cell immunotherapies for these diseases are currently limited…”
    Get full text
    Journal Article
  13. 13

    Functional miRNA Expression Library Screen Identifies miRNAs That Alter Proliferation and Differentiation in Acute Myeloid Leukemia by Morris, Valerie A., Cummings, Carrie, Meshinchi, Soheil, Oehler, Vivian

    Published in Blood (06-12-2014)
    “…Acute myeloid leukemia (AML) is characterized by increased self-renewal of leukemia stem/progenitor cells and failure of differentiation to mature myeloid…”
    Get full text
    Journal Article
  14. 14

    KDM7A Is Targeted By MiR-155 in Acute Myeloid Leukemia and Impacts Differentiation by Hughes, Maya D., Morris, Valerie A., Cummings, Carrie, Meshinchi, Soheil, Oehler, Vivian G.

    Published in Blood (03-12-2015)
    “…Acute myeloid leukemia (AML) is a heterogeneous disease that develops secondary to the acquisition of mutations that disrupt cell differentiation,…”
    Get full text
    Journal Article
  15. 15

    Krüppel-like Factors KLF4 and KLF2 Regulate microRNA-150 Expression in Myeloid Leukemias by Morris, Valerie A., Cummings, Carrie, Korb, Brendan, Boaglio, Sean M., Oehler, Vivian

    Published in Blood (06-12-2014)
    “…Background: Acute myeloid leukemia (AML) is characterized by increased self-renewal of leukemia stem/progenitor cells and failure of differentiation to mature…”
    Get full text
    Journal Article
  16. 16
  17. 17

    CD52 Expression In Leukemic Stem/Progenitor Cells by Oehler, Vivian G., Walter, Roland B., Cummings, Carrie, Sala-Torra, Olga, Stirewalt, Derek L., Fang, Min, Radich, Jerald P., Wood, Brent

    Published in Blood (19-11-2010)
    “…Abstract 2743 CD52 is a cell surface glycoprotein of unknown function that is expressed in B and T lymphocytes, macrophages, and monocytes, but is not…”
    Get full text
    Journal Article
  18. 18

    Preferentially Expressed Antigen in Melanoma (PRAME) Expression in Normal and CML CD34+ Progenitor Cells Impairs Myeloid Differentiation by Oehler, Vivian, Cummings, Carrie, Sabo, Kathleen, Wood, Brent, Guthrie, Katherine, Gooley, Ted, Pogosova-Agadjanyan, Era, Ladne, Paula, Stirewalt, Derek, Abkowitz, Janis L., Radich, Jerald

    Published in Blood (16-11-2008)
    “…PRAME, or the Preferentially Expressed Antigen in Melanoma, is an attractive therapeutic target in cancer treatment. It has been described as a…”
    Get full text
    Journal Article
  19. 19

    Planit by Cummings, Carrie

    Published in Adweek (2003) (28-11-2016)
    Get full text
    Magazine Article
  20. 20

    1936: John Lewis by Cummings, Carrie

    Published in Adweek (2003) (28-11-2016)
    Get full text
    Magazine Article